Longitudinal changes in echocardiographic measures of ventricular function after Fontan operation.


Journal

Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 04 2020
revised: 25 06 2020
accepted: 28 07 2020
pubmed: 14 8 2020
medline: 24 6 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

While numerous indices have been developed in an attempt to quantify ventricular function in patients with single ventricle heart disease after Fontan, there are little data on how these parameters change over time. A retrospective observational study was performed of individuals who underwent Fontan operation at Children's Hospital of Philadelphia (CHOP) in 2006 and 2007. Measurements of fractional area change (FAC), tricuspid annular planar systolic excursion (TAPSE), myocardial performance index (MPI), systolic to diastolic (s/d) ratio, and myocardial strain and strain rate were made offline. A composite outcome of protein-losing enteropathy (PLE), plastic bronchitis, transplant, or death was created, and change in function was compared between those who did and those who did not meet the outcome. There were 312 echocardiograms from 40 unique patients (75% male, 55% dominant right ventricle). The aggregate mean values for most assessed parameters were worse than what would be expected for a healthy age-matched population. The global longitudinal strain rate increased (worsened) by 0.014 (1/s) per year (P = .02), and the global circumferential strain rate increased (worsened) by 0.011 (1/s) per year (P = .01). There was no difference in the rate of change of ventricular function in the 6 patients who met the composite endpoint vs those who did not. This study demonstrates that global longitudinal strain rate and global circumferential strain rate decrease over 10 years following Fontan operation. These measures of ventricular performance may be early signs of cardiac dysfunction that predate more obvious echocardiographic signs of deterioration.

Sections du résumé

BACKGROUND
While numerous indices have been developed in an attempt to quantify ventricular function in patients with single ventricle heart disease after Fontan, there are little data on how these parameters change over time.
METHODS
A retrospective observational study was performed of individuals who underwent Fontan operation at Children's Hospital of Philadelphia (CHOP) in 2006 and 2007. Measurements of fractional area change (FAC), tricuspid annular planar systolic excursion (TAPSE), myocardial performance index (MPI), systolic to diastolic (s/d) ratio, and myocardial strain and strain rate were made offline. A composite outcome of protein-losing enteropathy (PLE), plastic bronchitis, transplant, or death was created, and change in function was compared between those who did and those who did not meet the outcome.
RESULTS
There were 312 echocardiograms from 40 unique patients (75% male, 55% dominant right ventricle). The aggregate mean values for most assessed parameters were worse than what would be expected for a healthy age-matched population. The global longitudinal strain rate increased (worsened) by 0.014 (1/s) per year (P = .02), and the global circumferential strain rate increased (worsened) by 0.011 (1/s) per year (P = .01). There was no difference in the rate of change of ventricular function in the 6 patients who met the composite endpoint vs those who did not.
CONCLUSION
This study demonstrates that global longitudinal strain rate and global circumferential strain rate decrease over 10 years following Fontan operation. These measures of ventricular performance may be early signs of cardiac dysfunction that predate more obvious echocardiographic signs of deterioration.

Identifiants

pubmed: 32789899
doi: 10.1111/echo.14826
pmc: PMC7721979
mid: NIHMS1620269
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1443-1448

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL125521
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007915
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Congenit Heart Dis. 2015 Mar-Apr;10(2):159-68
pubmed: 25130602
J Am Soc Echocardiogr. 2016 Mar;29(3):209-225.e6
pubmed: 26747685
Pediatr Cardiol. 2014 Oct;35(7):1253-8
pubmed: 24840648
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Echocardiography. 2017 Apr;34(4):587-593
pubmed: 28191731
Circ Cardiovasc Imaging. 2014 Nov;7(6):880-6
pubmed: 25270741
JACC Cardiovasc Imaging. 2017 Feb;10(2):212-213
pubmed: 27209113
Congenit Heart Dis. 2008 Jul-Aug;3(4):262-8
pubmed: 18715460
Pediatr Cardiol. 2018 Oct;39(7):1423-1432
pubmed: 29777281
J Am Soc Echocardiogr. 2013 Nov;26(11):1322-9
pubmed: 23928091
J Am Soc Echocardiogr. 2007 Jun;20(6):749-55
pubmed: 17543747
J Am Coll Cardiol. 2010 Apr 20;55(16):1721-8
pubmed: 20394877
J Am Soc Echocardiogr. 2005 Nov;18(11):1121-30
pubmed: 16275519
Int J Cardiol. 2017 Aug 1;240:172-177
pubmed: 28461021
J Cardiol. 1995 Dec;26(6):357-66
pubmed: 8558414
J Am Soc Echocardiogr. 2009 Aug;22(8):928-32
pubmed: 19553081
J Am Soc Echocardiogr. 2014 May;27(5):549-60, e3
pubmed: 24582163
J Am Soc Echocardiogr. 2011 Nov;24(11):1213-9
pubmed: 21856118
Heart Fail Clin. 2014 Jan;10(1):105-16
pubmed: 24275298
Echocardiography. 2016 Dec;33(12):1897-1902
pubmed: 27596010
Circulation. 2008 Jan 1;117(1):85-92
pubmed: 18071068
Heart. 2016 Jul 15;102(14):1081-6
pubmed: 27220691
J Am Soc Echocardiogr. 2007 Jun;20(6):764-70
pubmed: 17543749
J Am Soc Echocardiogr. 2019 May;32(5):643-650
pubmed: 30803862
Am J Cardiol. 2009 Aug 1;104(3):419-28
pubmed: 19616678
Circulation. 2014 Sep 9;130(11 Suppl 1):S32-8
pubmed: 25200053
J Am Soc Echocardiogr. 2009 Jun;22(6):715-9
pubmed: 19423286
J Am Coll Cardiol. 2017 Jun 6;69(22):2735-2744
pubmed: 28571639

Auteurs

Matthew J Campbell (MJ)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Michael D Quartermain (MD)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Meryl S Cohen (MS)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Jennifer Faerber (J)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Oluwatimelehin Okunowo (O)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Yan Wang (Y)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Valerie Capone (V)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Jenna DiFrancesco (J)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Laura Mercer-Rosa (L)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

David J Goldberg (DJ)

Department of Pediatrics, Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH